During the past decade, Institute of mental health, Peking University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of mental health, Peking University" #1 sponsor was "Peking University" with 4 trials, followed by "Si Tianmei" with 2 trials sponsored, "Nathan Kline Institute for Psychiatric Research" with 1 trials sponsored, "Otsuka Beijing Research Institute" with 1 trials sponsored and "Wave Neuroscience" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of mental health, Peking University" #1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator, "Xian-Janssen Pharmaceutical Ltd." with 1 trials as a collaborator and "Zhejiang Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institute of mental health, Peking University" are "Schizophrenia" (2 trials), "Affective Disorder" (1 trials), "Alzheimer's Disease" (1 trials), "Cigarette Smoking" (1 trials) and "Hyperprolactinemia" (1 trials). Many other conditions were trialed in "Institute of mental health, Peking University" in a lesser frequency.

Most popular intervention types in "Institute of mental health, Peking University" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aripiprazole" (1 trials), "Aripiprazole tablet, 5-30mg/day, oral, 6 weeks" (1 trials), "Buspirone" (1 trials), "Duloxetine" (1 trials) and "Escitalopram Pill" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of mental health, Peking University" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Institute of mental health, Peking University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institute of mental health, Peking University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of mental health, Peking University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".